--- title: "Tactile Systems Technology (TCMD) Projected to Post Quarterly Earnings on Tuesday" type: "News" locale: "en" url: "https://longbridge.com/en/news/275434133.md" description: "Tactile Systems Technology (NASDAQ:TCMD) is set to release its Q4 2025 earnings on February 17, with analysts expecting earnings of $0.44 per share. The company's stock opened at $27.30, with a market cap of $609.88 million. Recent insider trading saw VP Kristie Burns sell 5,139 shares. Institutional investors hold 83.43% of the stock, with several firms increasing their positions. Analyst ratings vary, with one upgrade to \"strong-buy\" and a consensus price target of $28.75. Tactile Systems specializes in medical devices for chronic edema treatment." datetime: "2026-02-10T09:29:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275434133.md) - [en](https://longbridge.com/en/news/275434133.md) - [zh-HK](https://longbridge.com/zh-HK/news/275434133.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275434133.md) | [繁體中文](https://longbridge.com/zh-HK/news/275434133.md) # Tactile Systems Technology (TCMD) Projected to Post Quarterly Earnings on Tuesday Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Tuesday, February 17th. Analysts expect the company to announce earnings of $0.44 per share for the quarter. Parties are encouraged to explore the company's upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 17, 2026 at 5:00 PM ET. ## Tactile Systems Technology Stock Performance - 3 Small Caps Drawing Insider and Institutional Support Shares of NASDAQ:TCMD opened at $27.30 on Tuesday. The firm has a 50 day simple moving average of $29.00 and a 200 day simple moving average of $20.50. Tactile Systems Technology has a 52 week low of $8.61 and a 52 week high of $31.38. The company has a market cap of $609.88 million, a PE ratio of 35.46 and a beta of 0.96. ## Insider Buying and Selling at Tactile Systems Technology In related news, VP Kristie Burns sold 5,139 shares of Tactile Systems Technology stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $28.85, for a total value of $148,260.15. Following the completion of the sale, the vice president owned 72,401 shares of the company's stock, valued at approximately $2,088,768.85. The trade was a 6.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.50% of the company's stock. ## Institutional Trading of Tactile Systems Technology - The Future of Medical Devices: Two Strong Buys You Can't Miss A number of institutional investors and hedge funds have recently made changes to their positions in TCMD. Federated Hermes Inc. increased its holdings in shares of Tactile Systems Technology by 42.7% during the 2nd quarter. Federated Hermes Inc. now owns 551,561 shares of the company's stock valued at $5,593,000 after acquiring an additional 165,163 shares during the last quarter. Norges Bank acquired a new position in Tactile Systems Technology during the second quarter valued at approximately $1,464,000. Bridgeway Capital Management LLC raised its position in shares of Tactile Systems Technology by 297.3% in the third quarter. Bridgeway Capital Management LLC now owns 133,878 shares of the company's stock valued at $1,853,000 after purchasing an additional 100,178 shares during the period. Paradigm Capital Management Inc. NY raised its position in shares of Tactile Systems Technology by 5.9% in the second quarter. Paradigm Capital Management Inc. NY now owns 1,618,600 shares of the company's stock valued at $16,413,000 after purchasing an additional 89,600 shares during the period. Finally, Franklin Resources Inc. lifted its stake in shares of Tactile Systems Technology by 240.3% in the third quarter. Franklin Resources Inc. now owns 75,152 shares of the company's stock worth $1,040,000 after buying an additional 53,069 shares during the last quarter. Institutional investors and hedge funds own 83.43% of the company's stock. ## Analyst Upgrades and Downgrades A number of brokerages have recently weighed in on TCMD. Wall Street Zen upgraded Tactile Systems Technology from a "buy" rating to a "strong-buy" rating in a report on Saturday, November 1st. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Tactile Systems Technology in a research note on Monday, December 29th. Zacks Research lowered shares of Tactile Systems Technology from a "strong-buy" rating to a "hold" rating in a research report on Monday, January 5th. Raymond James Financial set a $35.00 price target on shares of Tactile Systems Technology in a report on Monday, January 5th. Finally, Piper Sandler set a $35.00 price objective on shares of Tactile Systems Technology in a research note on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $28.75. **Get Our Latest Stock Analysis on TCMD** ## About Tactile Systems Technology (Get Free Report) Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company's platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function. At the core of Tactile Systems' product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design. ## Read More - Five stocks we like better than Tactile Systems Technology - The buying spree that no one is talking about - How to collect $500-$800 weekly (BlackRock's system) - Trump’s AI Secret: 100X Faster Than Nvidia - NEW LAW: Congress Approves Setup For Digital Dollar? - They just tried to kill gold _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Tactile Systems Technology Right Now? Before you consider Tactile Systems Technology, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list. While Tactile Systems Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [iShares US Healthcare Providers ETF (IHF.US)](https://longbridge.com/en/quote/IHF.US.md) - [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md) - [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md) - [Stt Strt® SPDR® S&P®HlthCrSvcsETF (XHS.US)](https://longbridge.com/en/quote/XHS.US.md) - [Tactile Systems Technology, Inc. (TCMD.US)](https://longbridge.com/en/quote/TCMD.US.md) ## Related News & Research - [ResMed Earnings Preview: What to Expect](https://longbridge.com/en/news/281019552.md) - [Heirloom Wealth Management Buys 16,650 Shares of Intuitive Surgical, Inc. $ISRG](https://longbridge.com/en/news/281345776.md) - [Boston Scientific (BSX) Gets a Hold from Erste Group](https://longbridge.com/en/news/281570952.md) - [Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group](https://longbridge.com/en/news/281455909.md) - [ENDRA Life Sciences Q4 net loss narrows](https://longbridge.com/en/news/281239377.md)